<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Daly Tran | Activity</title>
	<link>https://www.catswannabecats.com/members/giantcherry04/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/giantcherry04/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Daly Tran.</description>
	<lastBuildDate>Tue, 23 Jun 2026 10:40:48 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">0c8dd93aa924c62b79d44d8c2f163686</guid>
				<title>Daly Tran posted an update: After viewing the first and second VR, subjects responded to [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/25631/</link>
				<pubDate>Mon, 09 Jun 2025 11:27:07 -0400</pubDate>

									<content:encoded><![CDATA[<p>After viewing the first and second VR, subjects responded to STAI and the numerical rating scale (NRS) for satisfaction and side effects (nausea, dizziness, headache, and tiredness). Results Ten subjects participated in this study. The values of analyses are presented in the mean (SD). The age was 87.1 years (4.2), and the MMSE was 28.5 (1.8). <a href="https://www.selleckchem.com/products/nd646.html" rel="nofollow ugc">sell&hellip;</a><span class="activity-read-more" id="activity-read-more-25631"><a href="https://www.catswannabecats.com/activity/p/25631/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">0f290d4502da45e32361f2f4daad7943</guid>
				<title>Daly Tran posted an update: CpG methylation in transposons, exons, introns and [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/18308/</link>
				<pubDate>Tue, 03 Jun 2025 13:13:09 -0400</pubDate>

									<content:encoded><![CDATA[<p>CpG methylation in transposons, exons, introns and intergenic regions is important for long-term silencing, silencing of parasitic sequences and alternative promoters, regulating imprinted gene expression and determining X chromosome inactivation. Promoter CpG islands, although rich in CpG dinucleotides, are unmethylated and remain so during all&hellip;<span class="activity-read-more" id="activity-read-more-18308"><a href="https://www.catswannabecats.com/activity/p/18308/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f2623faa32191c217fcb1643fd91598e</guid>
				<title>Daly Tran posted an update: clinical setting.



Our study highlighted the presence of [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/9696/</link>
				<pubDate>Sat, 31 May 2025 23:01:21 -0400</pubDate>

									<content:encoded><![CDATA[<p>clinical setting.</p>
<p>Our study highlighted the presence of endothelial perturbation in TTS patients even at long-term from the index event. The residual thromboxane production and platelet aggregation still leave open the question about the use of low dose ASA in this clinical setting.The emergence of multidrug resistance (MDR) is one of the main&hellip;<span class="activity-read-more" id="activity-read-more-9696"><a href="https://www.catswannabecats.com/activity/p/9696/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">adaf4063fa3a3dfeee821b8b98b673e2</guid>
				<title>Daly Tran became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/7208/</link>
				<pubDate>Sat, 31 May 2025 18:26:11 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>